Voya Investment Management LLC Lowers Stock Holdings in Integer Holdings Co. (NYSE:ITGR)

Voya Investment Management LLC lessened its position in Integer Holdings Co. (NYSE:ITGR) by 5.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 14,567 shares of the medical equipment provider’s stock after selling 893 shares during the quarter. Voya Investment Management LLC’s holdings in Integer were worth $1,930,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of ITGR. Price T Rowe Associates Inc. MD increased its stake in Integer by 14.4% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 22,957 shares of the medical equipment provider’s stock worth $3,043,000 after purchasing an additional 2,891 shares during the period. Dark Forest Capital Management LP acquired a new position in shares of Integer in the fourth quarter valued at approximately $336,000. Hsbc Holdings PLC increased its stake in Integer by 115.8% during the 4th quarter. Hsbc Holdings PLC now owns 12,562 shares of the medical equipment provider’s stock worth $1,676,000 after buying an additional 6,741 shares during the period. Stifel Financial Corp lifted its holdings in Integer by 2.4% during the 4th quarter. Stifel Financial Corp now owns 32,290 shares of the medical equipment provider’s stock worth $4,279,000 after buying an additional 772 shares in the last quarter. Finally, Tower Research Capital LLC TRC boosted its position in Integer by 123.6% in the 4th quarter. Tower Research Capital LLC TRC now owns 4,459 shares of the medical equipment provider’s stock valued at $591,000 after buying an additional 2,465 shares during the period. Institutional investors and hedge funds own 99.29% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on ITGR. Benchmark cut their price objective on Integer from $150.00 to $140.00 and set a “buy” rating on the stock in a research report on Friday, April 25th. KeyCorp reduced their price target on Integer from $154.00 to $145.00 and set an “overweight” rating on the stock in a research report on Monday, April 21st. Oppenheimer cut Integer from an “outperform” rating to a “market perform” rating in a research note on Friday, February 21st. Truist Financial set a $150.00 target price on shares of Integer and gave the stock a “buy” rating in a research note on Friday, April 25th. Finally, StockNews.com downgraded shares of Integer from a “hold” rating to a “sell” rating in a research note on Friday, April 25th. One research analyst has rated the stock with a sell rating, two have given a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, Integer has an average rating of “Moderate Buy” and a consensus target price of $145.56.

Integer Stock Up 0.0 %

Shares of NYSE ITGR opened at $125.64 on Friday. The company has a quick ratio of 2.09, a current ratio of 2.95 and a debt-to-equity ratio of 0.62. The stock has a market cap of $4.38 billion, a PE ratio of 37.39, a price-to-earnings-growth ratio of 1.72 and a beta of 1.03. The business has a 50-day moving average price of $118.84 and a 200 day moving average price of $130.09. Integer Holdings Co. has a 52-week low of $104.93 and a 52-week high of $146.36.

Integer (NYSE:ITGR) last announced its earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 EPS for the quarter, beating analysts’ consensus estimates of $1.27 by $0.04. The business had revenue of $437.39 million during the quarter, compared to analysts’ expectations of $428.51 million. Integer had a net margin of 6.92% and a return on equity of 11.65%. The business’s revenue was up 7.3% compared to the same quarter last year. During the same period in the prior year, the company earned $1.14 earnings per share. Equities research analysts forecast that Integer Holdings Co. will post 6.01 earnings per share for the current year.

Insiders Place Their Bets

In other news, CEO Joseph W. Dziedzic sold 338,975 shares of the stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $123.17, for a total transaction of $41,751,550.75. Following the completion of the transaction, the chief executive officer now directly owns 47,000 shares of the company’s stock, valued at approximately $5,788,990. This represents a 87.82 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. 2.16% of the stock is owned by insiders.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.